Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03323684Completed
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Mansoura University. Primary endpoint: Cumulative postoperative fentanyl consumption at 24 hours. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03323684.